AKT1 and gastric cancer: In gastric cancer, the overexpression of miR-1269a can inhibit RASSF9 to activate the AKT signaling pathway, and up-regulate the transcription factors CDK2 and Cyclin D1, thereby inducing the transition of the cell cycle from the G1 phase to the S phase, promoting cell proliferation.